YY/T 1731-2020Human gene single nucleotide polymorphisms (SNP) detection kit (English PDF)
人基因单核苷酸多态性(SNP)检测试剂盒
This is a limited preview
Buy now to download the full PDF (23 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1731-2020 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
June 30, 2020
Implementation date
June 1, 2021
Scope
YY/T 1731-2020 is the English-translated version of 人基因单核苷酸多态性(SNP)检测试剂盒.
YY/T 1731-2020 is the Chinese pharmaceutical industry standard for kits that detect single nucleotide polymorphisms in human genes.
It sets the requirements, the test methods, the labels, the instructions for use and the rules for packaging, transport and storage, covering the agreement of the genotypes with reference materials, the detection limit in terms of template quantity and quality, the specificity between alleles, the repeatability and the stability, together with the controls the kit must carry.
It applies to kits whatever the methodology, among them real-time fluorescent PCR. Issued on 30 June 2020, it has applied since 1 June 2021.
Found what you need?
Document preview — YY/T 1731-2020
National Standard of the People's Republic of China
- Classification
- C 44
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword
- 1 Scope
- 2 Normative references
- 3 Terms and definitions
- 4 Requirements
Foreword
This standard was drafted in accordance with the rules given in GB/T 1.1-2009.
Please note that certain contents of this document may involve patents. Publication of this document The agency is not responsible for identifying these patents.
1 Scope
This standard specifies the requirements, test methods and labels, instructions for use, and packaging for human gene single nucleotide (SNP) polymorphism detection kits. The contents of installation, transportation and storage.
This standard applies to the quality control of single nucleotide polymorphism (SNP) detection kits in human genes. Kit methodology includes real-time fluorescence PCR method, PCR gene chip method, PCR electrophoresis method, PCR capillary electrophoresis analysis method, PCR high resolution melting curve method, flow fluorescence hybridization Method, time-of-flight mass spectrometry, pyrosequencing method, Sanger sequencing method, etc.
2 Normative references
The following documents are indispensable for the application of this document. For dated reference documents, only the dated version applies to this document. For undated references, the latest version (including all amendments) applies to this document.
GB/T 29791.2 Information provided by manufacturers of in vitro diagnostic medical devices (labeling) Part 2. Professional in vitro diagnostic reagents
3 Terms and definitions
The following terms and definitions apply to this document.
3.1 Single nucleotide polymorphism singlenucleotidepolymorphisms; SNP
The difference of a single base sequence at the level of normal individual genome, including base conversion and transversion.
4 Requirements
4.1 Appearance
The components of the kit should be complete and complete, no liquid leakage, and the signs and labels should be clear.
4.2 Reference product compliance
The test results of national reference materials and/or standardized corporate reference materials within the scope of the test kit should be consistent with known genotypes. The setting of reference products should follow the following principles.
a) All genotypes detectable within the scope of the kit;
b) For common genotypes in reference products, genomic DNA extracted from clinical samples or cell lines should be used;
c) In the composition of reference products used, the matrix of all genotype reference products should be the same or similar to the actual test sample matrix.
4.3 Analysis specificity
When testing specific national reference materials and/or standardized corporate reference materials, the test result should be negative.
The setting of analysis-specific reference products should follow the following principles.
a) A certain number of non-human genome samples should be included. common microbial samples;
b) A certain number of genotypes or gene mutation samples that are closely related to the target gene and outside the scope of the kit design should be included.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 23 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 1731-2020
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 29791.2-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0479-2026 — Medical diagnostic X-ray tube assemblies and X-ray source assemblies - Determination of maximum symmetric radiation field
Secure payment via Stripe
Payments accepted
YY/T 1731-2020
$95.00